Tag : Cladribine

Neurology

ORACLE-MS: Cladribine Effective in MS Subgroups

Newsemia
The recently approved disease-modifying therapy is expected to find a niche for patients with multiple sclerosis who fail other agents. Medscape Medical News Source link...
Neurology

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Newsemia
The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease...
Pharma / Biotech

Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study.

Newsemia
Related Articles Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study. Mult Scler Relat Disord. 2018 Oct 10;27:117-120 Authors:...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy